SCHEMBL10822158

SCHEMBL10822158

O=C1NC(=O)C(c2cccc3ccccc23)N1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ATM Q13315 1/20 0.53
MTNR1A P48039 2/20 0.47
KDM1A O60341 1/20 0.47
ALDH1A1 P00352 2/20 0.45
CASP1 P29466 1/20 0.45
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
TDP2 O95551 1/20 0.43
ALOX12 P18054 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
HTT P42858 1/20 0.43
GALK1 P51570 1/20 0.43
BLM P54132 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30588975 1.00 IDO1 (0.55) IDO1MEN1KMT2AATMMTNR1A
SCHEMBL6380847 0.79 IDO1 (0.54) IDO1MEN1KMT2AATMMTNR1A
SCHEMBL30023288 0.75 GAA (0.57) IDO1MEN1KMT2AKDM1AALDH1A1
SCHEMBL11652329 0.75 GAA (0.57) IDO1MEN1KMT2AKDM1AALDH1A1
SCHEMBL10656824 0.75 GSK3B (0.51) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL10575685 0.75 GSK3B (0.51) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL8922115 0.75 GSK3B (0.51) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL11645287 0.75 TDP1 (0.44) IDO1ALDH1A1MAPTHTTTDP1
SCHEMBL6277589 0.75 TDP1 (0.52) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL11566163 0.75 TDP1 (0.52) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-61025491-A None JP disclosed
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF Genetic Intelligence, Inc 2023-08-31 US disclosed
WO-2016044777-A1 HAT INHIBITORS AND METHODS FOR THEIR USE ABBVIE INC. (US) 2016-03-24 WO disclosed
JP-S6125491-A N-CARBAMOYL-D-NAPHTHYLGLYCINE AND ITS PREPARATION KANEGAFUCHI CHEM IND CO LTD 1986-02-04 JP disclosed
JP-S06125491-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF TARDBP, FUS, RBM17 IDO1 4873/4885MEN1 4364/4885KMT2A 3496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.